Paychex Earnings Calls
| Release date | Jun 24, 2026 |
| EPS estimate | $1.31 |
| EPS actual | $1.32 |
| EPS Surprise | 0.763% |
| Revenue estimate | 1.601B |
| Revenue actual | 1.606B |
| Revenue Surprise | 0.312% |
| Release date | Mar 25, 2026 |
| EPS estimate | $1.67 |
| EPS actual | $1.71 |
| EPS Surprise | 2.40% |
| Revenue estimate | 1.782B |
| Revenue actual | 1.809B |
| Revenue Surprise | 1.50% |
| Release date | Dec 19, 2025 |
| EPS estimate | $1.23 |
| EPS actual | $1.26 |
| EPS Surprise | 2.44% |
| Revenue estimate | 1.553B |
| Revenue actual | 1.558B |
| Revenue Surprise | 0.278% |
| Release date | Sep 30, 2025 |
| EPS estimate | $1.20 |
| EPS actual | $1.22 |
| EPS Surprise | 1.67% |
| Revenue estimate | 1.538B |
| Revenue actual | 1.54B |
| Revenue Surprise | 0.103% |
Last 4 Quarters for Paychex
Below you can see how PAYX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 30, 2025 |
| Price on release | $126.76 |
| EPS estimate | $1.20 |
| EPS actual | $1.22 |
| EPS surprise | 1.67% |
| Date | Price |
|---|---|
| Sep 24, 2025 | $128.27 |
| Sep 25, 2025 | $126.69 |
| Sep 26, 2025 | $128.21 |
| Sep 29, 2025 | $128.53 |
| Sep 30, 2025 | $126.76 |
| Oct 01, 2025 | $124.01 |
| Oct 02, 2025 | $123.42 |
| Oct 03, 2025 | $124.61 |
| Oct 06, 2025 | $124.37 |
| 4 days before | -1.18% |
| 4 days after | -1.89% |
| On release day | -2.17% |
| Change in period | -3.04% |
| Release date | Dec 19, 2025 |
| Price on release | $112.28 |
| EPS estimate | $1.23 |
| EPS actual | $1.26 |
| EPS surprise | 2.44% |
| Date | Price |
|---|---|
| Dec 15, 2025 | $115.31 |
| Dec 16, 2025 | $115.22 |
| Dec 17, 2025 | $116.70 |
| Dec 18, 2025 | $114.24 |
| Dec 19, 2025 | $112.28 |
| Dec 22, 2025 | $114.88 |
| Dec 23, 2025 | $114.10 |
| Dec 24, 2025 | $114.58 |
| Dec 26, 2025 | $114.19 |
| 4 days before | -2.63% |
| 4 days after | 1.70% |
| On release day | 2.32% |
| Change in period | -0.97% |
| Release date | Mar 25, 2026 |
| Price on release | $93.36 |
| EPS estimate | $1.67 |
| EPS actual | $1.71 |
| EPS surprise | 2.40% |
| Date | Price |
|---|---|
| Mar 19, 2026 | $91.71 |
| Mar 20, 2026 | $92.55 |
| Mar 23, 2026 | $93.50 |
| Mar 24, 2026 | $90.61 |
| Mar 25, 2026 | $93.36 |
| Mar 26, 2026 | $93.59 |
| Mar 27, 2026 | $91.68 |
| Mar 30, 2026 | $93.12 |
| Mar 31, 2026 | $92.12 |
| 4 days before | 1.80% |
| 4 days after | -1.33% |
| On release day | 0.246% |
| Change in period | 0.447% |
| Release date | Jun 24, 2026 |
| Price on release | $96.30 |
| EPS estimate | $1.31 |
| EPS actual | $1.32 |
| EPS surprise | 0.763% |
| Date | Price |
|---|---|
| Jun 17, 2026 | $97.58 |
| Jun 18, 2026 | $98.24 |
| Jun 22, 2026 | $95.93 |
| Jun 23, 2026 | $97.99 |
| Jun 24, 2026 | $96.30 |
| Jun 25, 2026 | $96.72 |
| Jun 26, 2026 | $99.90 |
| 4 days before | -1.31% |
| 4 days after | 3.74% |
| On release day | 0.436% |
| Change in period | 2.38% |
Paychex Earnings Call Transcript Summary of Q2 2026
Paychex reported solid Q2 FY2026 results: total revenue +18% to $1.6B and adjusted operating income +21%, driven by productivity improvements and contributions from the Paycor acquisition. Management Solutions revenue rose 21% (with Paycor contributing ~17 percentage points). The company reiterated progress on the Paycor integration, now expecting about $100 million of cost synergies for FY2026 and remaining on track for revenue synergy targets. The PEO business performed strongly (market-leading mid-single-digit worksite employee growth, near-record retention). Paychex emphasized AI as a strategic growth driver — announcing a patent-pending AI “knowledge mesh,” GenAI compliance and sales tools, and successful Agenic AI pilots that handled payroll inquiries with near 100% accuracy. Guidance: management reaffirmed FY2026 outlook but expects to finish toward the low end of the revenue ranges (given softer-than-expected revenue per client and smaller initial deal sizes); however, they raised adjusted diluted EPS guidance to +10–11% (from prior 9–11%). Balance sheet and capital allocation: cash and short-term investments ~$1.6B, total borrowings ~$5B, operating cash flow $445M in the quarter, and $514M returned to shareholders via dividends and buybacks in the quarter. Key investor risks/near-term headwinds include macro-driven price sensitivity among prospects, lower-than-assumed revenue per client/attachment rates, and some insurance agency headwinds within PEO/insurance.
Sign In
Buy PAYX